Literature DB >> 10096330

Perfusion-sensitive MRI of cerebral lymphomas: a preliminary report.

T Sugahara1, Y Korogi, Y Shigematsu, T Hirai, I Ikushima, L Liang, Y Ushio, M Takahashi.   

Abstract

PURPOSE: To date, there have been no systematic reports examining cerebral lymphomas with perfusion-sensitive MRI. We sought to determine the characteristics of perfusion-sensitive MRI of these tumors.
METHOD: Five primary and three secondary cerebral lymphomas were analyzed. None of the patients had a history of AIDS. Various areas of relative cerebral blood volume (rCBV) within tumor were analyzed, and maximum CBV ratios (CBV[tumor/contralateral]) were identified for evaluation.
RESULTS: In three primary and three secondary cerebral lymphomas, maximum CBV ratios were <2.5 (mean 1.50). In others, maximum CBV ratios were markedly higher than those of the white matter (5.38 and 5.42). Mean maximum rCBV ratios of primary and secondary cerebral lymphomas were 2.93 and 1.43, respectively. There was no significant difference between the two groups.
CONCLUSION: Cerebral lymphomas had a tendency to have low rCBV values. This information may be helpful in diagnosing these tumors.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10096330     DOI: 10.1097/00004728-199903000-00011

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  23 in total

1.  Blood volume of gliomas determined by double-echo dynamic perfusion-weighted MR imaging: a preliminary study.

Authors:  H Uematsu; M Maeda; N Sadato; T Matsuda; Y Ishimori; Y Koshimoto; H Kimura; H Yamada; Y Kawamura; Y Yonekura; H Itoh
Journal:  AJNR Am J Neuroradiol       Date:  2001 Nov-Dec       Impact factor: 3.825

2.  Percentage signal recovery derived from MR dynamic susceptibility contrast imaging is useful to differentiate common enhancing malignant lesions of the brain.

Authors:  R Mangla; B Kolar; T Zhu; J Zhong; J Almast; S Ekholm
Journal:  AJNR Am J Neuroradiol       Date:  2011-04-21       Impact factor: 3.825

3.  Dynamic susceptibility contrast-enhanced perfusion and conventional MR imaging findings for adult patients with cerebral primitive neuroectodermal tumors.

Authors:  Meng Law; Khuram Kazmi; Stephan Wetzel; Edwin Wang; Codrin Iacob; David Zagzag; John G Golfinos; Glyn Johnson
Journal:  AJNR Am J Neuroradiol       Date:  2004 Jun-Jul       Impact factor: 3.825

Review 4.  Neuroimaging in neuro-oncology.

Authors:  Soonmee Cha
Journal:  Neurotherapeutics       Date:  2009-07       Impact factor: 7.620

Review 5.  Clinical applications of dynamic susceptibility contrast perfusion-weighted MR imaging in brain tumours.

Authors:  A Romano; M C Rossi Espagnet; L F Calabria; V Coppola; L Figà Talamanca; V Cipriani; G Minniti; A Pierallini; L M Fantozzi; A Bozzao
Journal:  Radiol Med       Date:  2011-09-02       Impact factor: 3.469

6.  Comparison of first-pass and second-bolus dynamic susceptibility perfusion MRI in brain tumors.

Authors:  M Vittoria Spampinato; Caroline Wooten; Margaret Dorlon; Nada Besenski; Zoran Rumboldt
Journal:  Neuroradiology       Date:  2006-09-30       Impact factor: 2.804

Review 7.  Imaging biomarkers of angiogenesis and the microvascular environment in cerebral tumours.

Authors:  G Thompson; S J Mills; D J Coope; J P B O'Connor; A Jackson
Journal:  Br J Radiol       Date:  2011-12       Impact factor: 3.039

Review 8.  Update on brain tumor imaging.

Authors:  Soonmee Cha
Journal:  Curr Neurol Neurosci Rep       Date:  2005-05       Impact factor: 5.081

9.  Differentiation of primary central nervous system lymphomas and glioblastomas: comparisons of diagnostic performance of dynamic susceptibility contrast-enhanced perfusion MR imaging without and with contrast-leakage correction.

Authors:  C H Toh; K-C Wei; C-N Chang; S-H Ng; H-F Wong
Journal:  AJNR Am J Neuroradiol       Date:  2013-01-24       Impact factor: 3.825

10.  Perfusion MR imaging: clinical utility for the differential diagnosis of various brain tumors.

Authors:  Sung Ki Cho; Dong Gyu Na; Jae Wook Ryoo; Hong Gee Roh; Chan Hong Moon; Hong Sik Byun; Jong Hyun Kim
Journal:  Korean J Radiol       Date:  2002 Jul-Sep       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.